Digital Media briefs

Share this article:
Higher ad revenues and traffic to WebMD's physician and consumer web portals boosted second-quarter earnings, as ad revenue jumped 32% during the April-June period over the same period last year, to $100.6 million from $76 million. Traffic reached an average of 80.7 million unique users per month and total traffic of 1.8 billion page views during the quarter, increases of 35% and 22%, respectively, from a year ago. On the WebMD Professional Network, 1.5 million CME programs were completed. Contributions from consumer and professional ad revenue are roughly equal, the firm told MM&M.

An iPhone app aimed at helping prevent Spina Bifida was launched by VitaPath Genetics, the Spina Bifida Association and the National Council on Folic Acid. The VitaTrack Folate Tracker allows women to track their daily intake of folate and folic acid, and maintenance of adequate folic acid levels can reduce the risk of birth defects like Spina Bifida by 70%, the triumvirate said.

Elsevier's Skin & Allergy News Digital Network launched Product Zone, a targeted product and digital resource center for dermatologists, physicians and other healthcare professionals on its website (www.skinandallergynews.com).
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?